미국의 투시 검사 시장 규모, 점유율, 동향 분석 보고서 : 종류별, CPT별, 용도별, 부문별 예측(2026-2033년)

U.S. Fluoroscopy procedures Market Summary

The U.S. fluoroscopy procedures market size was estimated at USD 132.1 million in 2025 and is expected to reach a value of USD 182.7 million in 2033, growing at a CAGR of 4.1% from 2026 to 2033. The market growth is supported by the country's advanced healthcare infrastructure and high utilization of medical imaging for both diagnostic and interventional procedures.

Fluoroscopy enables real-time X-ray imaging, allowing physicians to guide minimally invasive procedures across specialties such as cardiology, orthopedics, gastroenterology, urology, and interventional radiology. In the United States, hospitals, catheterization laboratories, and ambulatory surgical centers widely rely on fluoroscopic guidance to perform complex procedures including angiography, catheter placement, spinal interventions, and gastrointestinal examinations. The growing preference for image-guided minimally invasive treatments has strengthened the role of fluoroscopy within the broader medical imaging ecosystem.

Technological advancements in imaging systems are playing a significant role in improving the efficiency, safety, and clinical outcomes of fluoroscopy-guided procedures. Hospitals and interventional imaging centers are increasingly replacing conventional fluoroscopy systems with advanced digital platforms that offer enhanced visualization, reduced radiation exposure, and improved workflow during minimally invasive procedures. According to the study published by National Library of Medicine in January 2026 evaluating fluoroscopy systems in clinical practice found that approximately 62% of surveyed fluoroscopy units now use flat-panel detectors (FPDs), which provide improved image quality and lower radiation dose compared with older image-intensifier systems. The study also noted that pulsed fluoroscopy capabilities are now nearly universal in modern systems, reflecting technological upgrades across hospitals and interventional imaging centers. These advancements support more precise image-guided interventions while improving radiation safety for both patients and healthcare professionals.

The rising prevalence of kidney and urinary tract diseases plays critical role in the growth of U.S. fluoroscopy procedures industry. Fluoroscopy provides real-time visualization during minimally invasive procedures, allowing physicians to guide catheters, stents, and other instruments with precision. As chronic kidney disease and urinary disorders continue to affect a significant portion of the U.S. population, healthcare facilities increasingly depend on fluoroscopy systems to support safe and efficient interventions. According to the Centers for Disease Control and Prevention (CDC) report "Chronic Kidney Disease in the United States, 2023," published in May 2024, more than 1 in 7 U.S. adults (about 35.5 million people) are estimated to have chronic kidney disease, highlighting a significant and growing healthcare burden. The CDC also notes that many individuals remain undiagnosed, increasing the need for early detection and image-guided clinical interventions. This rising disease prevalence supports growing demand for advanced diagnostic and treatment technologies, including fluoroscopy systems used in minimally invasive kidney and urinary tract procedures.

U.S. Fluoroscopy Procedures Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. fluoroscopy procedures market report based on product, application, and end use:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• C-Arms {including Mobile}
• Fixed Table-based
• Others
• CPT Outlook (Revenue, USD Million, 2021 - 2033)
• 54000-55899
• 50010-50437
• 50500-50593
• 50600-50980
• 51020-51610
• 52300-52356
• 53000-53899
• 74420, 74425, 74455
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
  • Not-for-Profit
  • For Profit
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Table of Contents

Chapter 1. U.S. Fluoroscopy Procedures Market: Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. CPT
  • 1.2.3. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. U.S. Fluoroscopy Procedures Market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
  • 2.2.1. Type outlook
  • 2.2.2. CPT outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Fluoroscopy Procedures Market: Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
  • 3.4.2. Market Restraint Analysis
• 3.5. U.S. Fluoroscopy Procedures Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.5.1.1. Supplier Power
    • 3.5.1.2. Buyer Power
    • 3.5.1.3. Substitution Threat
    • 3.5.1.4. Threat of New Entrants
    • 3.5.1.5. Competitive Rivalry
  • 3.5.2. PESTLE Analysis

Chapter 4. U.S. Fluoroscopy Procedures Market: Type Estimates & Trend Analysis

• 4.1. Type Movement Analysis & Market Share, 2025 & 2033
• 4.2. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.3. C-Arms {including Mobile}
  • 4.3.1. C-Arms {including Mobile} Market Estimates & Forecasts 2021 to 2033 (USD Million)
• 4.4. Fixed Table-based
  • 4.4.1. Fixed Table-based Market Estimates & Forecasts 2021 to 2033 (USD Million)
• 4.5. Others
  • 4.5.1. Others Market Estimates & Forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Fluoroscopy Procedures Market: CPT Estimates & Trend Analysis

• 5.1. CPT Movement Analysis & Market Share, 2025 & 2033
• 5.2. Market Size & Forecasts and Trend Analysis, by CPT, 2021 to 2033 (USD Million)
• 5.3. 54000-55899
  • 5.3.1. 54000-55899 Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.4. 50010-50437
  • 5.4.1. 50010-50437 Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.5. 50500-50593
  • 5.5.1. 50500-50593 Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.6. 50600-50980
  • 5.6.1. 50600-50980 Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.7. 51020-51610
  • 5.7.1. 51020-51610 Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.8. 52300-52356
  • 5.8.1. 52300-52356 Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.9. 53000-53899
  • 5.9.1. 53000-53899 Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.10. 74420, 74425, 74455
  • 5.10.1. 74420, 74425, 74455 Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Fluoroscopy Procedures Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2025 & 2033
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. For-Profit
    • 6.4.2.1. For-Profit Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Not-for-Profit
    • 6.4.3.1. Not-for-Profit Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 6.5. Specialty Clinics
  • 6.5.1. Specialty Clinics Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 6.6. Ambulatory Surgical Centers
  • 6.6.1. Ambulatory Surgical Centers Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. GE HealthCare
    • 7.5.1.1. Company Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Siemens Healthineers AG
    • 7.5.2.1. Company Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Koninklijke Philips N.V.
    • 7.5.3.1. Company Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Canon Medical Systems
    • 7.5.4.1. Company Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Shimadzu Corporation
    • 7.5.5.1. Company Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Dornier MedTech
    • 7.5.6.1. Company Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. UMG / DEL MEDICAL
    • 7.5.7.1. Company Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives